@jennifer-carroll Thanks so much. This is most helpful.
J
J Lancaster
@J Lancaster
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Posts
-
Copay content vs. HCP content -
Copay content vs. HCP contentGood afternoon,
Checking in on two facets of an HCP communication:
- Are there any considerations around promoting a copay program to HCPs in advance of it being available to Patients? E.g. "Soon we will be rolling out a copay program for patients..."
- Within the same communication to HCPs are we able to speak about other topics, for example the parent company and its heritage? Does any separation need to exist?
Many thanks in advance.